Institutional members access full text with Ovid®

Share this article on:

Marker Turned Target? A Case to Review Neprilysin in ALL (or Lessons Learned at the American Association for Cancer Research Meetings, 2006)

Kamen, Barton A. MD, PhD

Journal of Pediatric Hematology/Oncology: April 2006 - Volume 28 - Issue 4 - p 201-202
doi: 10.1097/01.mph.0000212921.16427.df
Invited Commentary

Cancer Institute of New Jersey, New Brunswick, NJ

Reprints: Barton A. Kamen, MD, PhD. Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08901 (e-mail:

© 2006 Lippincott Williams & Wilkins, Inc.